Cardiovascular Study
Learn More About Azure Outcomes Cardiovascular Study
This Phase III study aims to determine the effectiveness, safety, and tolerability of the study medication in participants who have had a heart attack or stroke, or at high risk of a first heart attack or stroke. This is an add-on medication to your standard cholesterol medicine.
Therapeutic Area: Cardiovascular
Phase: III
Status: Now Enrolling
You May Qualify if:
- You are 18+
- Men 50+, women 55+ with high LDL cholesterol and at least one of the following:
- clogged arteries
- high risk diabetes with kidney/eye/nerve damage or other documented artery disease
- You have already had a heart attack or stroke caused by clogged arteries, or leg artery surgery
- You are already on a strong cholesterol lowering statin
What’s Involved? You will have 8 study visits the first year and then 2 visits per year after that until the end of the study. Compensation is provided for time and travel. MediSphere may be able to arrange transportation for qualifying participants within our service area.
Call 812-471-4110 or complete the form on our website.
Want to speak with a Patient Recruitment Coordinator now?
Call 812-471-4110!